Sickle Cell Anemia Market

Global Sickle Cell Anemia Testing & Screening Market by Technologies (Hemoglobin Electrophoresis[Isoelectric Focusing and Others], High-performance Liquid Chromatography (HPLC), Point-of-Care Tests [Lateral Flow Immunoassay, Paper-based Rapid Diagnostics, and Others] and Other Tests), Age Groups (Newborn Screening (12 months and Below), Adult Screening (25 years to 60 years), and Other Age Groups (1 year to 25 years and Above 60 years)), Sector Types (Government Labs, Private Labs, Corporate Labs, and Public-Private-Partnerships (PPP)),and Regions (AsiaPacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2020-2027

  • Report ID: HC-178
  • Author: Growth Market Reports
  • Rating: 4.6
  • Total Reviews: 4
  • No. Of Pages: 156
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global sickle cell anemia testing & screening market is anticipated to expand at a substantial CAGR during the forecast period, between 2020 and 2027. Hemoglobinopathies include a category of inherited disorders, including sickle cell disease (SCD) that occurs due to defective hemoglobin damaging and deforming RBCs. The sickle cell disease affects millions of people across the globe and is common in the western hemisphere, Saudi Arabia, India, and countries in Sub-Saharan Africa and the Mediterranean region. The early detection of sickle cell anemia is essential for patient, as the medication for this condition is not easilyavailable and accessible.
 

Market Trends, Drivers, Restraints, and Opportunities:

  • Several government programs to promote the diagnosis of sickle cell anemia are projected to drivethe demand for sickle cell anemia testing & screening.
  • The implementation of newborn screening programs in sickle cell anemia affected areas such as Ghana, Kenya, and Democratic Republic of the Congo (DRC) is expected to fuel the market growth during the forecast period.
  • The development of hand-held, non-invasive digital devices for the identification of sickle cell disease is intended to create hindrances in the market.
  • Key market players concentrate on developing point-of-care tests using methods such as densitometry, microfluid electrophoresis, lateral flow immunoassay, and others that are accessible, compact, specific, and highly sensitive. Hence, this creates opportunities for the market.


Scope of the report:

Attributes

Details

Base Year

2019

Historic Data

2017 & 2018

Forecast Period

2020–2027

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

 
The report on the global sickle cell anemia testing & screening market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.


Sickle Cell Anemia Testing & Screening Market Segment Insights:

Higher demand for Point-of-Care Test Technology
In the terms of technologies, the sickle cell anemia testing & screening market can be segmented into hemoglobin electrophoresis, high-performance liquid chromatography (HPLC), point-of-care tests, and other tests. The hemoglobin electrophoresis segment is divided into isoelectric focusing and others. The point-of-care tests segment is further categorized as lateral flow immunoassay, paper-based rapid diagnostics, and others. The hemoglobin electrophoresis segment held a significant share of the market in 2019. The point-of-care technology segment is expected to grow at a high pace during the forecast period. Substantial developments in smartphone-based and paper-based assays are boosting the growth of the point-of-care tests segment.

Newborn screening segment held substantial market share in 2019
Based on age group, the sickle cell anemia testing & screening market is fragmented into newborn screening (12 months and below), adult screening (25years to 60 years), and other age groups (1 year to 25 years and above 60 years). The newborn screening segment held considerable market share in 2019. The adult screening segment is expected to expand at the significant CAGR during the forecast period. SCD diagnosis and management vary at various levels, depending on the age of the patient. These variations in SCD diagnosis and management are owing disparities in SCD-associated pain, co-morbidity, and psychosocial effects with respect to the age range of patients with sickle cell anemia.

Government laboratories segment is expected to grow during the forecast period
On the basis of test types, the market can be segregated into government labs, private labs, corporate labs, and public-private-partnerships (PPP). The government laboratories segment is expected to hold significant market share due to increasing developments in government laboratories. The PPP segment is expected to expand at a considerable CAGR owing to increasing investments in PPP during the forecast period.

North America dominates the global market
In terms of regions, the global sickle cell anemia testing & screening market is split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America constituted a considerable share of the global market in 2019. Newborn screening programs are introduced in all 50 states of the US and 8 provinces of Canada, providing a favorable environment for organizations participating in the market.
 

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sickle Cell Anemia Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Sickle Cell Anemia Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Sickle Cell Anemia Market - Supply Chain
  4.5. Global Sickle Cell Anemia Market Forecast
     4.5.1. Sickle Cell Anemia Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Sickle Cell Anemia Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Sickle Cell Anemia Market Absolute $ Opportunity
5. Global Sickle Cell Anemia Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Sickle Cell Anemia Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Sickle Cell Anemia Demand Share Forecast, 2019-2026
6. North America Sickle Cell Anemia Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Sickle Cell Anemia Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Sickle Cell Anemia Demand Share Forecast, 2019-2026
7. Latin America Sickle Cell Anemia Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Sickle Cell Anemia Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Sickle Cell Anemia Demand Share Forecast, 2019-2026
8. Europe Sickle Cell Anemia Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Sickle Cell Anemia Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Sickle Cell Anemia Demand Share Forecast, 2019-2026
9. Asia Pacific Sickle Cell Anemia Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Sickle Cell Anemia Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Sickle Cell Anemia Demand Share Forecast, 2019-2026
10. Middle East & Africa Sickle Cell Anemia Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Sickle Cell Anemia Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Sickle Cell Anemia Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Sickle Cell Anemia Market: Market Share Analysis
  11.2. Sickle Cell Anemia Distributors and Customers
  11.3. Sickle Cell Anemia Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

By Technologies

  • Hemoglobin Electrophoresis

    • Isoelectric Focusing

    • Others

  • High-performance Liquid Chromatography (HPLC)

  • Point-of-Care Tests

    • Lateral Flow Immunoassay

    • Paper-Based Rapid Diagnostics

    • Others

  • Other Tests

By Age Groups

  • Newborn Screening (12 Months and Below)

  • Adult Screening (25 Years to 60 Years)

  • Other Age Groups (1 Year to 25 Years & Above 60 Years)

By Sector Types

  • Government Labs

  • Private Labs

  • Corporate Labs

  • Public-Private-Partnerships (PPP)

By Regions

  • North America

  • Europe

  • Latin America

  • Asia Pacific

  • Middle East & Africa

 

Key players in the sickle cell anemia testing & screening market include STRECK, INC., Daktari Diagnostics, BIOMEDOMICS INC., Laboratory Corporation of America Holdings, Request A Test, Ltd., HALCYON BIOMEDICAL INCORPORATED, Silver Lake Research Corporation, HEMOTYPE, HEMEX HEALTH, Bio-Rad Laboratories, Inc., PerkinElmer Inc., and Quest Diagnostics. Mergers & acquisitions, collaborations, agreements, and partnerships are some growth strategies adopted by these players to strengthen their geographical presence.

Buy Report